Method for determination of fluoroquinolones based on the plasmonic interaction between their fluorescent terbium complexes and silver nanoparticles

Microchimica Acta

Volumn 174, Issue 3, 2011, Pages 353-360

  Kamruzzaman, Mohammad ^a   Alam, Al Mahmnur ^a   Lee, Sang Hak ^a,b   Suh, Yeoun Suk ^a   Kim, Young Ho ^a   Kim, Gyu Man ^a   Kim, Sung Hong ^b  

^a Kyungpook National University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Colloidal silver nanoparticles; Fluorescence; Levofloxacin; Moxifloxacin; Terbium

Indexed keywords

EID: 80051671635     PISSN: 00263672     EISSN: 14365073     Source Type: Journal    
DOI: 10.1007/s00604-011-0633-0     Document Type: Article

References (49)

1. Shen LL (1993) Quinoline DNA interaction. Quinolone antimicrobial agents, 2nd edn. American Society for Microbiology, Washington, pp 77-95.
2. Suh B, Lorber B (1995) Quinolones. Med Clin North Am 79: 869-894.
3. Shen LL, Kohlbrenner WE, Weigl D, Baranowski J (1989) Mechnism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem 264: 2973-2978.
4. Djabarouti S, Boselli E, Allaouchiche B, Ba B, Nguyena AT, Gordien JB, Bernadou JM, Saux MC, Breilh D (2004) Determination of levofloxacin in plasma, broncho-alveolar lavage and bone tissues by high performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J Chrom B 799: 165-172.
5. Ji HY, Jeong DW, Kim YH, Kim HH, Sohn DR, Lee HS (2006) Hydrophilic interaction liquid chromatography tandem mass spectrometry for the determination of levofloxacin in human plasma. J Pharm Biomed Anal 41: 622-627.
6. Rosenstiel NV, Adam D (1994) Quinolone antibacterials: an update of their pharmacology and therapeutic use. Drugs 47: 872-901.
7. Donati M, Fermepin MR, Olmo A, Apote LD, Cevenini R (1999) Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. J Antimicrob Chemother 43: 825-827.
8. Vishwanathan K, Bartlett MG, Stewart JT (2002) Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 30: 961-968.
9. Pestova E, Millichap JJ, Noskin GA, Peterson LR (2000) Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother 45: 583-590.
10. Muijsers RBR, Jarvis B (2002) Moxifloxacin: in uncomplicated skin and skin structure infections. Drugs 62: 967-973.
11. El-Brashy AM, Metwally MES, El-Sepai FA (2004) Spectrophotometric determination of some fluoroquinolone antibacterials by binary complex formation with xanthene dyes. IL FARMACO 59: 809-817.
12. Patil T, Pore Y (2008) Development and validation of simultaneous UV spectrophotometric method for the determination of levofloxacin and ambroxol in tablets. J Kor Chem Socity 52: 622-629.
13. Kassab NM, do Amaral MS, Singh AK, Santoro MIRM (2010) Development and validation of UV spectrophotometric method for determination of Levofloxacin in pharmaceutical dosage forms. Quim Nova 33: 968-971.
14. Ulu ST (2009) Rapid and sensitive spectrofluorimetric determination of enrofloxacin, levofloxacin and ofloxacin with 2, 3, 5, 6-tetrachloro-p-benzoquinone. Spectrochim Acta A 72: 1038-1042.
15. González JAO, Mochón MC, de la Rosa FJB (2000) Spectrofluorimetric determination of levofloxacin in tablets, human urine and serum. Talanta 52: 1149-1156.
16. Du LM, Yang YQ, Wang QM (2004) Spectrofluorometric determination of certain quinolone through charge transfer complex formation. Anal Chim Acta 516: 237-243.
17. Ocaña JA, Barragán FJ, Callejón M (2000) Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum. Analyst 125: 2322-2325.
18. Liu YM, Cao JT, Tian W, Zheng YL (2008) Determination of levofloxacin and norfloxacin by capillary electrophoresis with electrochemiluminescence detection and applications in human urine. Electrophoresis 29: 3207-3212.
19. Tsai YH, Bair MJ, Hu CC (2007) Determination of levofloxacin in human urine with capillary electrophoresis and fluorescence detector. J Chin Chem Soc 54: 991-995.
20. Möller JG, Staß H, Heinig R, Blaschke G (1998) Capillary electrophoresis with laser-induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes. J Chromatogr B 716: 325-334.
21. Radi A, El-Sherif Z (2000) Determination of levofloxacin in human urine by adsorptive square-wave anodic stripping voltammetry on a glassy carbon electrode. Talanta 58: 319-324.
22. Trindade MAG, da Silva GM, Ferreira VS (2005) Determination of moxifloxacin in tablets and human urine by square-wave adsorptive voltammetry. Microchem J 81: 209-216.
23. Trindade MAG, Cunha PAC, de Araújo TA, da Silva GM, Ferreira VS (2006) Interaction study of moxifloxacin with Cu(II) ion using square-wave voltammetry and its application in the determination in tablets. Ecl Quím São Paulo 31: 31-38.
24. Gao X, Yao G, Guo N, An F, Guo X (2007) A simple and rapid high performance liquid chromatography method to determine levofloxacin in human plasma and its use in a bioequivalence study. Drug Discov Ther 1: 136-140.
25. Siewert S (2006) Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. J Pharm Biomed Anal 41: 1360-1362.
26. Cheng FC, Tsai TR, Chen YF, Hung LC, Tsai TH (2002) Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography. J Chromatogr A 961: 131-136.
27. Liang H, Kays MB, Sowinski KM (2002) Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B 772: 53-63.
28. Laban-Djurdjevľc A, Jelikľc-Stankov M, Djurdjevľ P (2006) Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. J Chromatogr B 844: 104-111.
29. Chan KP, Chu KO, Lai WWK, Choy KW, Wang CC, Lam DSC, Pang CP (2006) Determination of oXoxacin and moxiXoxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection. Anal Biochem 353: 30-36.
30. Nguyen HA, Grellet J, Ba BB, Quentin C, Saux MC (2004) Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. J Chromatogr B 810: 77-83.
31. Ocaña JA, Callejón M, Barragán FJ (2000) Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum. Analyst 125: 1851-1854.
32. Ocaña JA, Barragán FJ, Callejón M, De la Rosa F (2004) Application of lanthanide-sensitised chemiluminescence to the determination of levofloxacin, moxifloxacin and trovafloxacin in tablets. Microchim Acta 144: 207-213.
33. Lakowicz JR (2001) Radiative decay engineering: biophysical and biomedical applications. Anal Biochem 298: 1-24.
34. Geddes CD, Lakowicz JR (2002) Metal-enhanced fluorescence. J Fluoresc 12: 121-129.
35. Sokolov K, Chumanov G, Cotton TM (1998) Enhancement of molecular fluorescence near the surface of colloidal metal films. Anal Chem 70: 3898-3905.
36. Aslan K, Malyn SN, Zhang Y, Geddes CD (2008) Conversion of just continuous metallic films to large particulate substrates for metal-enhanced fluorescence. J Appl Phys 103: 084307-7.
37. Aslan K, Previte MJR, Zhang Y, Geddes CD (2008) Metal-enhanced fluorescence from nanoparticulate zinc films. J Phys Chem C 112: 18368-18375.
38. Aslan K, Gryczynski I, Malicka J, Matveeva E, Lakowicz JR, Geddes CD (2005) Metal-enhanced fluorescence: an emerging tool in biotechnology. Curr Opin Biotechnol 16: 55-62.
39. Aslan K, Lakowicz JR, Szmacinski H, Geddes CD (2004) Metal-enhanced fluorescence solution-based sensing platform. J Fluoresc 14: 677-679.
40. 2 nanoballs. J Fluoresc 17: 127-131.
41. Yu X, Jiang Z, Wang Q, Guo Y (2010) Silver nanoparticle-based Chemiluminescence enhancement for the determination of norfloxacin. Microchim Acta 171: 17-22.
42. Guo JZ, Cui H, Zhou W, Wang W (2008) Ag nanoparticle-catalyzed chemiluminescent reaction between luminol and hydrogen peroxide. J Photochem Photobiol A 193: 89-96.
43. Raveendran P, Fu J, Wallen SL (2003) Completely "green" synthesis and stabilization of metal nanoparticles. J Am Chem Soc 125: 13940-1394.
44. Wang X, Shen B, Zhao H, Jin L (2007) Determination of ulifloxacin by terbium-sensitized fluorescence with second-order scattering and its applications. Anal Scien 23: 1373-1376.
45. Yu F, Zhou D, Wu K, Chen F (2008) Sensitive determination of prulifloxacin by its fluorescence enhancement on terbium(III)-sodium dodecylbenzene sulfonate system. Anal Lett 41: 3124-3137.
46. Zhu R, Kok WT (1997) Determination of Catecholamines and related compounds by capillary electrophoresis with postcolumn terbium complexation and sensitized luminescence detection. Anal Chem 69: 4010-4016.
47. Veiopoulou CJ, Ioannou PC, Lianidou ES (1997) Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum. J Pharm Biomed Anal 15: 1839-1844.
48. Zhang Y, Aslan K, Previte MJR, Geddes CD (2007) Metal-enhanced fluorescence: surface plasmons can radiate a fluorophore's structured emission. Appl Phys Lett 90: 053107-3.
49. Aslan K, Previte MJR, Zhang Y, Geddes CD (2008) Surface plasmon coupled fluorescence in the ultraviolet and visible spectral regions using zinc thin films. Anal Chem 80: 7304-7312.